Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Arvind Chaudhry (NPI 1750336236)

Field	Value
Entity Type	Individual
Organization	Arvind Chaudhry
Address	6001 North Mayfair
City	Spokane
State	WA
ZIP	99208
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 23, 2006

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the available data: total Medicare revenue is $2.9M and there is no Medicaid billing on file, indicating the practice’s reimbursement exposure and reporting are concentrated in Medicare rather than state programs. Analysts should treat Medicaid as absent when modeling payer mix or negotiating with state plans.

Revenue concentration is extreme: the precomputed top 3 Medicare codes account for 79.8% of this provider’s total Medicare revenue, driven by J9271 (64.5%), J0897 (9.7%), and 99213 (5.6%). This indicates a small set of services dominate financial performance and should be the focus of utilization or reimbursement reviews.

The code mix points to a high-throughput oncology infusion practice centered on immunotherapy and supportive agents: J9271 (44K claims, $1.8M revenue) is the primary driver, supported by J0897 (14.7K claims, $279.3K revenue) and chemotherapy administration 96413 (772 claims, $79.5K revenue). Diagnostic and imaging codes such as 78815 (106 claims, $135.2K revenue) and A9800 (55 claims, $39.8K revenue) further suggest integrated use of advanced PET/CT and novel tracers for cancer staging and management.

The provider is a national outlier for pembrolizumab administration: J9271 ranks #21 of 1841 providers nationally (99th percentile; extreme outlier), with 44K claims and $1.8M in Medicare revenue. This position indicates dominant national volume for this specific high-cost immunotherapy relative to peers and implies significant clinical focus or a specialized infusion infrastructure.

Other oncology services also show above-typical scale: J0897 ranks #558 of 10057 providers (94th percentile; notably above typical national volume) and chemotherapy administration 96413 ranks #196 of 7514 providers (97th percentile; notably above typical national volume). In addition, M0010 (441 claims, $30.9K revenue) ranks #6 of 544 providers nationally (99th percentile; notably above typical national volume), signaling active participation in enhanced oncology model payments and structured oncology care delivery.

Ambulatory visit volume for established patients is unusually high: 99213 appears with 2.5K claims, $161.7K revenue and ranks #429 of 457151 providers nationally (100th percentile; extreme outlier). This suggests the provider maintains heavy office-based management alongside infusion services, implying significant face‑to‑face follow-up and care coordination capacity.

The provider has long tenure in the NPI registry (enumerated 2006-05-23 (~20 years ago)), which aligns with the scale and concentration of specialty oncology services observed; the long-active enumeration supports interpreting high volumes as established practice patterns rather than a recent surge.

Most ancillary codes (imaging, labs, additional infusion add‑ons) report typical or unremarkable volumes relative to national peers—examples include 78815 (70th percentile; typical), A9800 (0th percentile; typical), and multiple lab codes with high percentiles labeled as typical. Combined with no Medicaid billing on file, this pattern points to a Medicare-focused oncology operation with concentrated revenue streams and limited exposure to state Medicaid populations, which may affect case mix, payer negotiation leverage, and access considerations for Medicaid beneficiaries.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

59 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	44,000	$40	$1.8M
J0897	Injection, denosumab, 1 mg	14,700	$20	$279.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	2,450	$70	$161.7K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	110	$1,280	$135.2K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	770	$100	$79.5K
A9800	Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie	60	$720	$39.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	410	$100	$39.4K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	400	$80	$30.9K
M0010	Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services	440	$70	$30.9K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	150	$200	$28.8K

Showing 1–10 of 59

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 59 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Arvind Chaudhry — 13 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

59 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	1	30	9,600	$40	$465.7K
J0897	4	150	1,800	$20	$57.9K
78815	34	110	50	$430	$50.3K
A9800	1	10	60	$720	$39.8K
J2506	3	10	360	$80	$28.2K
A9552	11	40	50	$280	$23.8K
96413	2	160	80	$110	$15K
J9217	8	80	90	$130	$14.9K
99214	955	10,860	100	$80	$13.6K
74177	219	550	110	$80	$12.3K

Showing 1–10 of 59

Related Providers

Other providers that share a Tax Identification Number (TIN) with Arvind Chaudhry, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Wilfredo Blasini	FL	Clinical Pathology Physician	$16.9M	$307.9K
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
American Oncology Partners PA	OH	Hematology & Oncology Physician	$0	$11.8M
Robert Mcdonald	AZ	Diagnostic Radiology Physician	$7.5M	$0
David Smith	MD	Hematology & Oncology Physician	$6.4M	$0
Stephen Divers	AR	Hematology & Oncology Physician	$3.9M	$1.5K
Robert Muldoon	AR	Hematology & Oncology Physician	$3.2M	$0
Bradley Sumrall	GA	Medical Oncology Physician	$3.1M	$0
Linda Hendricks	GA	Specialist	$3.1M	$0

Nearby Providers

Other providers in the same ZIP code as Arvind Chaudhry, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
American Behavioral Health Systems, Inc.	WA	Substance Abuse Rehabilitation Facility	$0	$60.5M
Providence Health & Services - Washington	WA	General Acute Care Hospital	$0	$43.2M
Community Health Association Of Spokane	WA	Federally Qualified Health Center (FQHC)	$0	$22.5M
Excelsior Wellness	WA	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$11.8M
Center For Pediatric Therapy	WA	Physical Therapy Clinic/Center	$0	$9M
Emergency Physician Services Ps Holy Emergency Center	WA	Emergency Medicine Physician	$0	$8.2M
Patrick Bradley, Dds, PLLC	WA	Dental Clinic/Center	$0	$5.7M
Community Health Association Of Spokane	WA	Federally Qualified Health Center (FQHC)	$0	$5.5M
Ortc, LLC	WA	Methadone Clinic	$0	$3.4M
Mirela Andrei	WA	Medical Oncology Physician	$1M	$0

Arvind Chaudhry — Billing Profile & Reimbursement Data

Sign up for Arvind Chaudhry — Billing Profile & Reimbursement Data policy alerts

Arvind Chaudhry — Billing Profile & Reimbursement Data

Sign up for Arvind Chaudhry — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References